Cementos Bio Financials
| CEMENTOS | CLP 1,400 100.00 7.69% |
Cementos |
Understanding current and past Cementos Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cementos Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Cementos Bio's assets may result in an increase in income on the income statement.
Cementos Bio Stock Summary
Cementos Bio competes with Aguas Andinas, Parq Arauco, Enel Generacin, and Sociedad Matriz. Cementos Bio Bio S.A. manufactures and sells cement in Chile and internationally. The company was founded in 1957 and is based in Providencia, Chile. CEMENTOS BIO is traded on Commodity Exchange in Exotistan.| Instrument | Chile Stock View All |
| Exchange | Chilean Stock Exchange |
| ISIN | CLP2234F1031 |
| Business Address | Alfredo Barros ErrAzuriz |
| Sector | Basic Materials |
| Industry | Building Materials |
| Benchmark | Dow Jones Industrial |
| Website | cbb.cl |
| Phone | 56 22 560 7000 |
| Currency | CLP |
You should never invest in Cementos Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cementos Stock, because this is throwing your money away. Analyzing the key information contained in Cementos Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Cementos Bio Key Financial Ratios
Cementos Bio's financial ratios allow both analysts and investors to convert raw data from Cementos Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Cementos Bio over time and compare it to other companies across industries.| Return On Equity | 0.0705 | |||
| Return On Asset | 0.0042 | |||
| Beta | 0.14 | |||
| Z Score | 0.6 |
Cementos Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cementos Bio's current stock value. Our valuation model uses many indicators to compare Cementos Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cementos Bio competition to find correlations between indicators driving Cementos Bio's intrinsic value. More Info.Cementos Bio B is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.06 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Cementos Bio B is roughly 16.79 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cementos Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cementos Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Cementos Bio B Systematic Risk
Cementos Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cementos Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Cementos Bio B correlated with the market. If Beta is less than 0 Cementos Bio generally moves in the opposite direction as compared to the market. If Cementos Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cementos Bio B is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cementos Bio is generally in the same direction as the market. If Beta > 1 Cementos Bio moves generally in the same direction as, but more than the movement of the benchmark.
Cementos Bio November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cementos Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cementos Bio B. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cementos Bio B based on widely used predictive technical indicators. In general, we focus on analyzing Cementos Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cementos Bio's daily price indicators and compare them against related drivers.
| Information Ratio | 0.1285 | |||
| Maximum Drawdown | 86.26 | |||
| Potential Upside | 3.37 |
Other Information on Investing in Cementos Stock
Cementos Bio financial ratios help investors to determine whether Cementos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cementos with respect to the benefits of owning Cementos Bio security.